Skip to main content
SpringerLink
Log in

Women and Coronary Artery Disease

  • Chapter
  • First Online:
Coronary Artery Disease

Part of the book series: Cardiovascular Medicine ((CVM))

Abstract

Coronary artery disease was long considered to be a disease primarily affecting men. However, recent statistics indicate that it is also the most frequent cause of death in women. Awareness campaigns have tried to address the disparities in knowledge regarding women and coronary artery disease. This chapter highlights some of the differences and similarities in treatment strategies for women compared with those for men. It also reviews some of the causes of chest pain in women and various diagnostic modalities.

2012 Mayo Foundation for Medical Education and Research

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACA:

American College of Cardiology

AHA:

American Heart Association

CAC:

Coronary artery calcification

CAD:

Coronary artery disease

CARE:

Cholesterol and Recurrent Events

CASS:

Coronary Artery Surgery Study

CIMT:

Carotid intima media thickening

CRUSADE:

Can Rapid Risk Stratification of Unstable Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines

FRISC:

Fragmin and Fast Revascularization During Instability in Coronary Artery Disease

GPIIB/IIIa:

Glycoprotein IIB/IIIa

GUSTO:

Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndrome

HDL:

High-density lipoprotein

HDL-C:

High-density lipoprotein cholesterol

HERS II:

Heart and Estrogen/progestin Replacement Study follow-up

HR:

Hazard ratio

JNC 7:

Seventh Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure

JUPITER:

Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin

LDL:

Low-density lipoprotein

LDL-C:

Low-density lipoprotein cholesterol

METEOR:

Measuring Effects on Intima-Media Thickness: An Evaluation of Rosuvastatin

NCEP:

National Cholesterol Education Program

NSTEMI:

Non–ST-elevation myocardial infarction

PROVE-IT TIMI-22:

Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22

PURSUIT:

Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy

RR:

Relative risk

STEMI:

ST-elevation myocardial infarction

TACTIMS-TIMI 18:

Treat Angina With Aggrastat and Determine Cost of Therapy With an Invasive or Conservative Strategy–Thrombolysis in Myocardial Infarction 18

TIMI:

Thrombolysis in Myocardial Infarction

WHI:

Women’s Health Initiative

WISE:

Women’s Ischemia Syndrome Evaluation

References

  1. National Institutes of Health; National Heart, Lung, and Blood Institute. Fact book: fiscal year 2010 [Internet]. Washington (DC): US Department of Health and Human Services; [cited 26 Jun 2012]. Available from: http://www.nhlbi.nih.gov/about/factbook-10/FactBook_2010.pdf.

  2. Lewis SJ. Cardiovascular disease in postmenopausal women: myths and reality. Am J Cardiol. 2002;89(12A):5E–10.

    Article  PubMed  Google Scholar 

  3. Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3(2):120–7.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Doroodchi H, Abdolrasulnia M, Foster JA, Foster E, Turakhia MP, Skelding KA, et al. Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract. 2008;9:42.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Barnhart J, Lewis V, Houghton JL, Charney P. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative. Womens Health Issues. 2007;17(2):93–100.

    Article  PubMed  Google Scholar 

  6. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993;88(4 Pt 1):1999–2009.

    Article  CAS  PubMed  Google Scholar 

  7. Lurie N, Fremont A, Jain AK, Taylor SL, McLaughlin R, Peterson E, et al. Racial and ethnic disparities in care: the perspectives of cardiologists. Circulation. 2005;111(10):1264–9.

    Article  PubMed  Google Scholar 

  8. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17(1):143–52.

    PubMed  Google Scholar 

  9. Palaniappan LP, Araneta MR, Assimes TL, Barrett-Connor EL, Carnethon MR, Criqui MH, et al. Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association. Circulation. 2010;122(12):1242–52. Erratum in: Circulation. 2010;122(19):e516. Council on Cardiovascular Nursing [added].

    Google Scholar 

  10. Nasir K, Shaw LJ, Liu ST, Weinstein SR, Mosler TR, Flores PR, et al. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol. 2007;50(10):953–60.

    Article  PubMed  Google Scholar 

  11. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008;117(14):1787–801.

    Article  PubMed  Google Scholar 

  12. Watkins LO. Epidemiology and burden of cardiovascular disease. Clin Cardiol. 2004;27(6 Suppl 3):III2–6.

    Article  PubMed  Google Scholar 

  13. Parikh SV, Enriquez JR, Selzer F, Slater JN, Laskey WK, Wilensky RL, et al. Association of a unique cardiovascular risk profile with outcomes in Hispanic patients referred for percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2009;104(6):775–9. Epub 2009 Jul 25.

    Article  PubMed Central  PubMed  Google Scholar 

  14. van Ryn M, Burgess D, Malat J, Griffin J. Physicians’ perceptions of patients’ social and behavioral characteristics and race disparities in treatment recommendations for men with coronary artery disease. Am J Public Health. 2006;96(2):351–7.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.

    Article  CAS  PubMed  Google Scholar 

  16. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611–9. Erratum in: JAMA. 2007;297(13):1433.

    Google Scholar 

  17. Blair ML. Sex-based differences in physiology: what should we teach in the medical curriculum? Adv Physiol Educ. 2007;31(1):23–5.

    Article  PubMed  Google Scholar 

  18. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243–62. Errata in: Circulation. 2011;124(16):e427. Circulation. 2011;123(22):e624.

    Google Scholar 

  19. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, et al. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med. 2005;353(5):468–75.

    Article  CAS  PubMed  Google Scholar 

  20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. Epub 2003 May 14. Erratum in: JAMA. 2003;290(2):197.

    Google Scholar 

  21. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23(12):2269–76.

    Article  CAS  PubMed  Google Scholar 

  22. Ramirez-Exposito MJ, Martinez-Martos JM. Hypertension, RAS, and gender: what is the role of aminopeptidases? Heart Fail Rev. 2008;13(3):355–65.

    Article  CAS  PubMed  Google Scholar 

  23. Hernandez Schulman I, Raij L. Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II. Am J Nephrol. 2006;26(2):170–80.

    Article  CAS  PubMed  Google Scholar 

  24. Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-h blood pressure profile of postmenopausal women. Am J Hypertens. 2000;13(9):1039–41.

    Article  CAS  PubMed  Google Scholar 

  25. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, et al.; The INDANA Investigators. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med. 1997;126(10):761–7.

    Google Scholar 

  26. Frazier CG, Shah SH, Armstrong PW, Bhapkar MV, McGuire DK, Sadowski Z, et al. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. Am Heart J. 2005;150(6):1260–7.

    Article  CAS  PubMed  Google Scholar 

  27. Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women’s Health Initiative. Hypertension. 2000;36(5):780–9.

    Article  CAS  PubMed  Google Scholar 

  28. Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med. 2002;5(2):27–37.

    PubMed  Google Scholar 

  29. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.

    Article  CAS  PubMed  Google Scholar 

  30. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas. 1990;12(4):321–31.

    Article  CAS  PubMed  Google Scholar 

  31. Bittner V. Lipoprotein abnormalities related to women’s health. Am J Cardiol. 2002;90(8A):77i–84.

    Article  CAS  PubMed  Google Scholar 

  32. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115(11):1481–501. Erratum in: Circulation. 2007;115(15):e407.

    Google Scholar 

  33. Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T, et al. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study). Circulation. 2008;117(4):494–502.

    Article  CAS  PubMed  Google Scholar 

  34. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294(3):326–33.

    Article  CAS  PubMed  Google Scholar 

  35. Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation. 2004;110(18):2824–30.

    Article  PubMed  Google Scholar 

  36. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.

    Google Scholar 

  37. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med. 1995;332(26):1758–66.

    Article  CAS  PubMed  Google Scholar 

  38. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993;22(7):1788–94.

    Article  CAS  PubMed  Google Scholar 

  39. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med. 2005;142(10):813–20.

    Article  PubMed  Google Scholar 

  40. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–8.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol. 2005;45(9):1413–8.

    Article  PubMed  Google Scholar 

  42. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness Jr E. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 1984;311(15):953–9.

    Article  CAS  PubMed  Google Scholar 

  43. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.

    Article  PubMed  Google Scholar 

  44. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: The Framingham Study. JAMA. 1988;260(23):3456–60. Erratum in: JAMA 1989;261(13):1884

    Google Scholar 

  45. Wong ND, Pio JR, Franklin SS, L’Italien GJ, Kamath TV, Williams GR. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol. 2003;91(12):1421–6.

    Article  PubMed  Google Scholar 

  46. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005;162(11):1089–97.

    Article  PubMed  Google Scholar 

  47. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article  CAS  PubMed  Google Scholar 

  48. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317(21):1303–9.

    Article  CAS  PubMed  Google Scholar 

  49. Douglas P, editor. Cardiovascular health and disease in women. 1st ed. Philadelphia: Saunders; 1993.

    Google Scholar 

  50. Gramenzi A, Gentile A, Fasoli M, D’Avanzo B, Negri E, Parazzini F, et al. Smoking and myocardial infarction in women: a case-control study from northern Italy. J Epidemiol Community Health. 1989;43(3):214–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111(5):682–96.

    Article  PubMed  Google Scholar 

  52. Mark DB, Hlatky MA, Harrell Jr FE, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987;106(6):793–800.

    Article  CAS  PubMed  Google Scholar 

  53. Mark DB, Shaw L, Harrell Jr FE, Hlatky MA, Lee KL, Bengtson JR, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991;325(12):849–53.

    Article  CAS  PubMed  Google Scholar 

  54. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED. Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998;32(6):1657–64. Erratum in: J Am Coll Cardiol. 1999;33(1):28.

    Google Scholar 

  55. Weiner DA, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F, et al. Exercise stress testing: correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med. 1979;301(5):230–5.

    Article  CAS  PubMed  Google Scholar 

  56. Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994;308(6933):883–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  57. Raggi P, Shaw LJ, Berman DS, Callister TQ. Gender-based differences in the prognostic value of coronary calcification. J Womens Health (Larchmt). 2004;13(3):273–83.

    Article  Google Scholar 

  58. Lester SJ, Eleid MF, Khandheria BK, Hurst RT. Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis. Mayo Clin Proc. 2009;84(3):229–33.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Crouse 3rd JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O’ Leary DH, et al.; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007;297(12):1344–53. Epub 2007 Mar 25.

    Google Scholar 

  60. Kyker KA, Limacher MC. Gender differences in the presentation and symptoms of coronary artery disease. Curr Womens Health Rep. 2002;2(2):115–9.

    PubMed  Google Scholar 

  61. McGuire DK, Newby LK, Biswas MS, Hochman JS. The elderly, women, and patients with diabetes mellitus. In: Theroux P, editor. Acute coronary syndromes: a companion to Braunwald’s heart disease. 1st ed. Philadelphia: Saunders; 2003. p. 553–73.

    Google Scholar 

  62. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307(8):813–22.

    Article  CAS  PubMed  Google Scholar 

  63. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 Suppl):S4–20.

    Article  PubMed  Google Scholar 

  64. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction: National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341(4):217–25.

    Article  CAS  PubMed  Google Scholar 

  65. Kannel WB, Wilson PW, D’Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136(2):205–12.

    Article  CAS  PubMed  Google Scholar 

  66. Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, et al.; The GUSTO-IIb Investigators. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation. 1998;98(18):1860–8.

    Google Scholar 

  67. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA. 2002;288(24):3124–9.

    Article  PubMed  Google Scholar 

  68. Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation. 2005;111(7):940–53.

    Article  PubMed  Google Scholar 

  69. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879–87.

    Article  CAS  PubMed  Google Scholar 

  70. Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E, FRISC II Study Group Investigators. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? J Am Coll Cardiol. 2001;38(1):41–8.

    Article  CAS  PubMed  Google Scholar 

  71. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction): developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):652–726.

    Article  Google Scholar 

  72. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation. 2008;117(2):296–329. Erratum in: J Am Coll Cardiol. 1999;33(1):289.

    Google Scholar 

  73. Hasdai D, Califf RM, Thompson TD, Hochman JS, Ohman EM, Pfisterer M, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol. 2000;35(1):136–43.

    Article  CAS  PubMed  Google Scholar 

  74. Gottlieb S, Harpaz D, Shotan A, Boyko V, Leor J, Cohen M, et al. Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation. 2000;102(20):2484–90.

    Article  CAS  PubMed  Google Scholar 

  75. Hochman JS, Tamis-Holland JE. Acute coronary syndromes: does sex matter? JAMA. 2002;288(24):3161–4.

    Article  PubMed  Google Scholar 

  76. Antoniucci D, Valenti R, Moschi G, Migliorini A, Trapani M, Santoro GM, et al. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol. 2001;87(3):289–93.

    Article  CAS  PubMed  Google Scholar 

  77. Vakili BA, Kaplan RC, Brown DL. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Circulation. 2001;104(25):3034–8.

    Article  CAS  PubMed  Google Scholar 

  78. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients: Antiplatelet Trialists’ Collaboration. BMJ. 1994;308(6921):81–106. Erratum in: BMJ. 1994;308(6943):1540.

    Google Scholar 

  79. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352(13):1293–304.

    Article  CAS  PubMed  Google Scholar 

  80. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. N Engl J Med. 1998;339(7):436–43.

    Article  Google Scholar 

  81. Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-LaPointe NM, et al.; CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005;294(24):3108–16. Erratum in: JAMA. 2006;295(6):628.

    Google Scholar 

  82. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350(15):1495–504. Erratum in: N Engl J Med. 2006;354(7):778.

    Google Scholar 

  83. Pedersen TR, Kjekshus J, Berg K, Olsson AG, Wilhelmsen L, Wedel H, et al. Cholesterol lowering and the use of healthcare resources: results of the Scandinavian Simvastatin Survival Study. Circulation. 1996;93(10):1796–802. Erratum in: Circulation 1996;94(4):849.

    Google Scholar 

  84. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al.; Cholesterol and Recurrent Events Trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335(14):1001–9.

    Google Scholar 

  85. Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59(6):572–82. Erratum in: J Am Coll Cardiol. 2012;59(16):1491.

    Google Scholar 

  86. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–12.

    Article  CAS  PubMed  Google Scholar 

  87. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288(1):49–57. Erratum in: JAMA. 2002;288(9):1064.

    Google Scholar 

  88. Magliano DJ, Rogers SL, Abramson MJ, Tonkin AM. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis. BJOG. 2006;113(1):5–14.

    Article  CAS  PubMed  Google Scholar 

  89. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al.; the Atherosclerosis Risk in Communities Study Investigators. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328(15):1069–75.

    Google Scholar 

  90. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999;100(7):717–22.

    Article  CAS  PubMed  Google Scholar 

  91. Grodstein F, Manson JE, Stampfer MJ, Willett WC. The discrepancy between observational studies and randomized trials of menopausal hormone therapy. Ann Intern Med. 2004;140(9):764–5.

    Article  PubMed  Google Scholar 

  92. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265(14):1861–7.

    Article  CAS  PubMed  Google Scholar 

  93. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991;115(6):455–6.

    Article  CAS  PubMed  Google Scholar 

  94. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(24):2993–9.

    Article  PubMed  Google Scholar 

  95. Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, Reichek N, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141(5):735–41.

    Article  CAS  PubMed  Google Scholar 

  96. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948–53.

    Article  PubMed  Google Scholar 

  97. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293(4):477–84.

    Article  CAS  PubMed  Google Scholar 

  98. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart. 2002;87(6):513–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  99. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J. 2006;27(12):1408–15.

    Article  PubMed  Google Scholar 

  100. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris, I: a variant form of angina pectoris: preliminary report. Am J Med. 1959;27:375–88.

    Article  CAS  PubMed  Google Scholar 

  101. Mayer S, Hillis LD. Prinzmetal’s variant angina. Clin Cardiol. 1998;21(4):243–6.

    Article  CAS  PubMed  Google Scholar 

  102. Okumura K, Osanai T, Kosugi T, Hanada H, Ishizaka H, Fukushi T, et al. Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response. J Am Coll Cardiol. 2000;36(6):1847–52.

    Article  CAS  PubMed  Google Scholar 

  103. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizaka H, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol. 1996;27(1):45–52.

    Article  CAS  PubMed  Google Scholar 

  104. Onaka H, Hirota Y, Shimada S, Kita Y, Sakai Y, Kawakami Y, et al. Clinical observation of spontaneous anginal attacks and multivessel spasm in variant angina pectoris with normal coronary arteries: evaluation by 24-hour 12-lead electrocardiography with computer analysis. J Am Coll Cardiol. 1996;27(1):38–44.

    Article  CAS  PubMed  Google Scholar 

  105. Hung MJ, Cheng CW, Yang NI, Hung MY, Cherng WJ. Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease. Int J Cardiol. 2007;117(1):37–44.

    Article  PubMed  Google Scholar 

  106. Yuksel UC, Celik T, Iyisoy A, Kursaklioglu H, Amasyali B, Kose S. Polymorphic ventricular tachycardia induced by coronary vasospasm: a malignant case of variant angina. Int J Cardiol. 2007;121(2):210–2.

    Article  PubMed  Google Scholar 

  107. Pepine CJ, el-Tamimi H, Lambert CR. Prinzmetal’s angina (variant angina). Heart Dis Stroke. 1992;1(5):281–6.

    CAS  PubMed  Google Scholar 

  108. Raxwal V, Gupta K. Images in cardiovascular medicine: coronary artery spasm. Circulation. 2006;113(14):e689–90.

    Article  PubMed  Google Scholar 

  109. Chen HS, Pinto DS. Images in clinical medicine: Prinzmetal’s angina. N Engl J Med. 2003;349(1):e1.

    Article  PubMed  Google Scholar 

  110. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries: long-term follow-up of 277 patients. Eur Heart J. 1996;17(7):1015–21.

    Article  CAS  PubMed  Google Scholar 

  111. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long-term prognosis of patients with variant angina: a comparative study between western and Japanese populations. Int J Cardiol. 1988;18(3):331–49.

    Article  CAS  PubMed  Google Scholar 

  112. Hurst RT, Prasad A, Askew 3rd JW, Sengupta PP, Tajik AJ. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 2010;3(6):641–9.

    Article  PubMed  Google Scholar 

  113. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004;43(10):1791–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Washington University School of Medicine, St. Louis, MO, USA

    Nishath A. Quader MD

  2. Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, USA

    Susan Wilansky MD

  3. Medicine Department, College of Medicine, Mayo Clinic, Rochester, MN, USA

    Susan Wilansky MD

Authors
  1. Nishath A. Quader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan Wilansky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan Wilansky MD .

Editor information

Editors and Affiliations

  1. Cardiology Division, President, Texas Heart Institute, Houston, Texas, USA

    James T. Willerson

  2. Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

    David R. Holmes, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Quader, N.A., Wilansky, S. (2015). Women and Coronary Artery Disease. In: Willerson, J., Holmes, Jr., D. (eds) Coronary Artery Disease. Cardiovascular Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-2828-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2828-1_7

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2827-4

  • Online ISBN: 978-1-4471-2828-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation